The role of incretins in salt-sensitive hypertension
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Nephrology,Internal Medicine
Reference31 articles.
1. Glucagon-like peptide 1 receptor expression in primary porcine proximal tubular cells.;Schlatter;Regul Pept,2007
2. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies.;Lewington;Lancet,2002
3. Continuous subcutaneous infusion of glucagon-like peptide 1 lowers plasma glucose and reduces appetite in type 2 diabetic patients.;Toft-Nielsen;Diabetes Care,1999
4. Effects of exenatide on diabetes, obesity, cardiovascular risk factors, and hepatic biomarkers in patients with type 2 diabetes.;Nielsen;J Diabetes Sci Technol,2008
5. Exenatide once weekly for the treatment of type 2 diabetes.;Malone;Expert Opin Investig Drugs,2009
Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. GLP-1 mimetics and diabetic ketoacidosis: possible interactions and clinical consequences;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-08-22
2. Serum and Adipose Dipeptidyl Peptidase 4 in Cardiovascular Surgery Patients: Influence of Dipeptidyl Peptidase 4 Inhibitors;Journal of Clinical Medicine;2022-07-26
3. Not only incretins for diabetic kidney disease—beneficial effects by DPP-4 inhibitors;Kidney International;2021-02
4. Blood Pressure-Lowering Effect of Newer Antihyperglycemic Agents (SGLT-2 Inhibitors, GLP-1 Receptor Agonists, and DPP-4 Inhibitors);American Journal of Cardiovascular Drugs;2020-08-11
5. Multicenter prospective observational study of teneligliptin, a selective dipeptidyl peptidase-4 inhibitor, in patients with poorly controlled type 2 diabetes: Focus on glycemic control, hypotensive effect, and safety Chikushi Anti-Diabetes Mellitus Trial-Teneligliptin (CHAT-T);Clinical and Experimental Hypertension;2019-04-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3